The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thats the problem with companies like this. They forget that they do not exist to make tablets. They exist to make money.
I am completely with you with the name change. Chosen by a pharmacist not a businessman.
CJ39
“ It’s just been a disastrous 18 months since the Stalicla deal was announced. I’d like to hear from posters like xxxInvestorxxx, K3VMC, Trickymatters, Mozax for their take on things. I know we’ve not always agreed but they were all very civil and reasonable.”
Sorry, I’ve only just spotted this post.
I really like the Chronos acquisition.
“ Acquisition of Chronos Therapeutics, which features a neuropsychiatry portfolio including two assets developed to late pre-clinical stage and which sits within a resurgent area for Big Pharma, for £899,481 up front, and up to £2.5m in milestone payments, all in Evgen shares.”
Quite apart from the late stage products brought in with Chronos, they now have their neuropsychiatry experience and contacts. Since Stalicla may have decided to play hardball with EVG, they have the backup of taking sfx01 back off them and developing it through TheraCryf.
Clearly, whoever saddled them with “TheraCryf” a) thought they were being frightfully clever and b) has never been gifted a copy of “Marketing for Dummies”. Thankfully, their success will not depend on anything other than sfx001 efficacy in one or more of the many research projects going on. They are all worthy projects, but I think the gliablastoma research will get some additional prominence, due to President Biden’s interest in that field.
I added on the acquisition news, but I anticipated the subsequent slide - no stocks seem capable of sustaining any rise in this market. I added again today, so managed to get my average to 2.18p. If they have any commercial success at all, the first 3x should be an easy reach, but long term it could be stunning. If and could. Just my opinion.
I’ll be adding, gently.
I'm with you on that DSFLAT.
TR1s stacking up nicely. None of them mine.
Stalicla maybe decided to play hardball, but the new partners will be ready to pick up from them, if they walk away.
I bought on the first news of the Stalicla deal and have been averaging all the way down since lol
Obviously hoping for some positive news from Stalicla
Is this a private investor buying in for a 4% stake?
Sounds promising DSFLAT - have you been a buyer recently, as one million shares might have cost you a fair bit a year or so ago.
I am tempted to buy a few more, as I reseached Stalicla and they do seem to say they are progressing but evauating.
HL will take 1M shares off me in one go...
In the past I have struggled to get a bid on £500 sell
Make of that what you will
Good luck with your flutter here.
Only around an average daily volume and the actual sums involved were really not remotely 'bigger buys'.
While it can be fun (and occasionally informative) reading these chat boards, I hope you have in addition to this, at least reviewed all the RNS material for at least the last 12-18 months as a partial basis for your purchase?
I mean, it is entirely your money to play with as you see fit, but goodness me, of all the punts to take, you chose this one?!
As long as you have only put in what you can potentially afford to lose entirely, is my only piece of advice to you, on the basis you say you are new to share trading.
Keep in mind, if/when this gets a spike at some point (and assuming it does not top out around this level from a much lower price than today), there are likely to be quite a few other traders and trapped investors who are going to be looking to get out too.
And if the Stal deal ends up the way of the Juv deal, then, well, like I said, good luck with your flutter, because then the potential upside really is going to be hard to imagine, IMO.
Well I am pretty new to all this share trading but I see there was a good number of bigger buys today.
In reply to the last post and having read a lot about them on other message boards here, they do seem like they have feather their pockets but don't a lot of directors do that and then announce a string of good news that sends the share price sky high only for the directors to sell loads of options and really win bug time.
So I am hoping that it will rocket within a few months, they never do these things quickly or it would seem they knew all along. Only guessing and hoping, as I hope to make a few quid, to pay for my horses keep.
It has all gone very quiet on here. Has everyone given up on it? This share had so much support, investors who 100% believed in the company.
I am really puzzled why there is still no update two months on. It obviously isn’t an oversight like many of us hoped. But it was clear there were problems last summer when EVG changed its guidance of $5.5m to be received by end of 2023 to ‘up to $5.5m expected in 2024. That raised alarm bells for me and I fortunately sold out at 2.55p.
What is clear is that the board know a lot more than they have told the mug shareholders. For example issuing shares last month to dilute the shares by 50%, why do that if they are expecting money imminently, especially after the new finance guy talked about wanting to create value for shareholders when he was appointed. But clearly even the board are puzzled as they issued a dispute notice believing they fulfilled their commitments. It seems like Stalicla are an awkward partner, it doesn’t bode well for future payments if they can’t even honour the second one.
Just because there are 'many more crap companies' (than this one), does not make this a quality company, worthy of investment, either.
As witnessed by at least two of the major shareholders, who decided to allow their positions to be diluted, rather than participate in this raise.
Pathetic levels of inside buying, with dilution that was so bad for existing holders, you struggle to see a bull case, even if you really want to.
Entirely justified lack of trust/faith in the BOD, based on their track record...since the year dot really.
Lack of Stal update continues. After the Juv abortion, faith in the entire pipeline hanging by a thread, IMO.
Absolutely nothing on the old cancer trial stuff either for ages, which was what first interested me all those years ago. If it is dead, just tell us, rather than the corporate waffle about progressing talks, which is/was clearly rubbish.
And yes, from a technical POV, so many far better technical trade prospects right now, so it fails from both an investment and a technical chart perspective too, IMO.
None of which means it might not have a (short) spike or two at some point before it goes pop once and for all (not 100% certain of course, yet IMO virtually so)...but again, better rainbows to chase than this one for a pure punt too, IMO.
But no harm in having different opinions :) GLA.
Is todays price not a new low? Surely if good news comes from Switzerland the buyers today will haver snached a bargain. There are many more crap companies that do not have around £3 million in the bank whose shares are many times higher than this.
I have not yet had another nibble though as the chart does not get any better but I maybe wishing I had any day I think but once burnt twice shy.
EasyP,
Whilst many are awaiting news from Switzerland,
some are chucking in the towel.
Everyone to their own trades/convictions
PI's with grande testiculos?
And maybe a very small predatory brain?
Just ordinary PI's essentially, I think.
But IMO today's RNS is more important (and another negative) as we see another of the large shareholders has chosen to be diluted, rather than continue to fund this lifestyle outfit.
Any idea who the buyers represent? 6% Stake so far.
It’s just been a disastrous 18 months since the Stalicla deal was announced. I’d like to hear from posters like xxxInvestorxxx, K3VMC, Trickymatters, Mozax for their take on things. I know we’ve not always agreed but they were all very civil and reasonable.
Hope you all had a nice Easter break. Surprised to see that anyone took up the raise offer.
Equally surprised to see inside buying, although then again, it was buttons really, so not surprised in that sense. Hardly the kind of investment sizes that inspire confidence, especially given the salaries, lack of prior inside buying etc. Rubbish deal for existing holders, naturally. Part and parcel for AIM, along with the lack of consequences for BOD failure.
Also looks like the biggest holder has come to similar conclusions to some of us. GLA.
£40K late trade ? (not £40 lol)
MM's were keen to take a large dummy sell from me on Friday ?
£40 late trade ?!?
MM's were keen to take a large dummy sell from me on Friday ?
Is this the Alice in Wonderland site ?
HL will take a decent sized sell which is Very unusual, might be collecting shares for buyer
Rose tinted glasses in full effect ;-)
8 weeks today since Evgen issued their dispute over milestone payment not received and still no updates. I mean what the af is going on here? Is it too much to expect the shareholders to have an update on this, after all the $5.5m was originally said to be received by end of 2023.
I suppose the one glimmer of light is that at least Stalicla haven’t pulled the plug on the deal.
At just 0.78 a little toe in the water once again, as soon there might be news about the delayed receipt, which hopefully will be positive.